Klaus von Bergmann - JoVE Visualize

Showing results (61-70 of 64) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 64 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 19, 2005

Disposition of oral and intravenous pravastatin in MRP2-deficient TR- ratsKari T Kivistö, Olaf Grisk, Ute Hofmann, et al.

Neurobiology of Aging|February 26, 2003

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's diseaseM Axel Wollmer, Johannes R Streffer, Dieter Lütjohann, et al.

Journal of Lipid Research|June 24, 2004

Phytosterolemia on the island of Kosrae: founder effect for a novel ABCG8 mutation results in high carrier rate and increased plasma plant sterol levelsEphraim Sehayek, Hannah J Yu, Klaus von Bergmann, et al.

Clinical Pharmacology and Therapeutics|March 4, 2006

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humansStefan Oswald, Sierk Haenisch, Christiane Fricke, et al.

Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 64 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 19, 2005

Disposition of oral and intravenous pravastatin in MRP2-deficient TR- ratsKari T Kivistö, Olaf Grisk, Ute Hofmann, et al.

Neurobiology of Aging|February 26, 2003

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's diseaseM Axel Wollmer, Johannes R Streffer, Dieter Lütjohann, et al.

Journal of Lipid Research|June 24, 2004

Phytosterolemia on the island of Kosrae: founder effect for a novel ABCG8 mutation results in high carrier rate and increased plasma plant sterol levelsEphraim Sehayek, Hannah J Yu, Klaus von Bergmann, et al.

Clinical Pharmacology and Therapeutics|March 4, 2006

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humansStefan Oswald, Sierk Haenisch, Christiane Fricke, et al.

Pageof 7